Skip to content

Ayahuasca: all studies

Page 141 of 167: studies 1,401 to 1,410 of 1,661, newest first. Back to the ayahuasca overview

Research

Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study

Frontiers in Psychiatry June 16, 2021 Dóra Révész, Genís Ona, Giordano Novak Rossi et al. 42 citations

Background: One of the main public health strategies adopted at the beginning of the COVID-19 pandemic consisted of implementing strict lockdowns to stop the transmission of the virus. Despite being an effective measure, the confinement and the associated social isolation create a stressful, potentially lengthy situations that has been proven to have several psychological consequences. Given...

Natural and Experimental Evidence Drives Marmosets for Research on Psychiatric Disorders Related to Stress

Frontiers in Behavioral Neuroscience June 11, 2021 Maria Bernardete Cordeiro de Sousa, Maria Lara Porpino de Meiroz Grilo, Nicole Leite Galvão‐coelho 7 citations

Knowledge of the behavioral ecology of marmosets carried out in their natural habitat associated with the advent of a non-invasive technique for measuring steroid hormones in feces has made a significant contribution to understanding their social relationships and sexual strategies. These studies showed that they are mainly monogamous, live in relatively stable social groups according to a...

DOI: 10.3389/fnbeh.2021.674256 (opens in new tab) Behavioral syndrome Context archaeology Developmental psychology Marmoset +7

The need for publicly funded research on therapeutic use of psychedelic drugs

World Psychiatry May 18, 2021 Wayne Hall 17 citations

A psychedelic drug is one that “produces thought, mood and perceptual changes otherwise rarely experienced except in dreams, contemplative and religious exaltation, flashes of vivid involuntary memory, and acute psychosis”1. It does so “without causing physical addiction, craving, major physiological disturbances, delirium, disorientation or amnesia”1. The “classic psychedelics” include...

The Failed Globalization of Psychedelic Drugs in the Early Modern World

The Historical Journal May 10, 2021 Benjamin Breen 5 citations

Abstract This article reassesses what has been called ‘the puzzle of distribution’: why did some drugs rapidly emerge as global consumer goods in the era of the Columbian Exchange, whereas others remained restricted to regional centres of usage? I argue here that the early modern concept of transplantation allows us to approach the puzzle of distribution from a novel perspective. Early modern...

DOI: 10.1017/s0018246x21000224 (opens in new tab) Full text (opens in new tab) Commodification Globalization Consumption sociology Centrality +8

Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm

Australian & New Zealand Journal of Psychiatry March 21, 2021 Daniel Perkins, Jerome Sarris, Susan L. Rossell et al. 53 citations

The medical use of psychedelic substances (e.g. psilocybin, ayahuasca, lysergic acid diethylamide and 3,4-methylenedioxymethamphetamine) is attracting renewed interest, driven by a pressing need for research and development of novel therapies for psychiatric disorders, as well as promising results of contemporary studies. In this Viewpoint, we reflect upon the ‘Clinical Memorandum on...

DOI: 10.1177/0004867421998785 (opens in new tab) Psilocybin Mental health Psychotherapist Hallucinogen

On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review

ACS Pharmacology & Translational Science March 11, 2021 Richard J. Zeifman, Nikhita Singhal, Leah Breslow et al. 60 citations

Use of classic psychedelics (e.g., psilocybin, ayahuasca, and lysergic acid diethylamide) is increasing, and psychedelic therapy is receiving growing attention as a novel mental health intervention. Suicidality remains a potential safety concern associated with classic psychedelics and is, concurrently, a mental health concern that psychedelic therapy may show promise in targeting. Accordingly,...

Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year

Hypertension March 8, 2021 Otto Simonsson, Peter S. Hendricks, Robin Carhart-Harris et al. 36 citations

Using data from the National Survey on Drug Use and Health (2005–2014), weighted to be representative of the US adult population, the present study investigated the association between lifetime classic psychedelic use and hypertension in the past year among adults in the United States. The results showed that respondents who reported having used a classic psychedelic at least once in their...

Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples.

Molecules March 5, 2021 Joana Gonçalves, Ângelo Luís, Eugenia Gallardo et al. 39 citations

The consumption of new psychoactive substances (NPSs) has been increasing, and this problem affects several countries worldwide. There is a class of NPSs of natural origin, consisting of plants and fungi, which have a wide range of alkaloids, responsible for causing relaxing, stimulating or hallucinogenic effects. The consumption of some of these substances is prompted by religious beliefs and...

DOI: 10.3390/molecules26051397 (opens in new tab) Full text (opens in new tab) Analytical methodologies Psychoactive effects Toxicological aspects Traditional uses +17

Connected to the spirit of the frog: An Internet-based survey on Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): Motivations for use, settings and subjective experiences

Journal of Psychopharmacology March 4, 2021 Tomislav Majić, Meike Sauter, Felix Bermpohl et al. 14 citations

Background/aim: Kambô is a name for the secretion of the Giant Maki Frog ( Phyllomedusa bicolor), which has been used by indigenous cultures from the Amazonas basin and has recently become popular in alternative healing circles in Western countries, with a certain overlap with psychedelic self-exploration. Methods: We carried out an online-based survey in English (54.92%) and German...

DOI: 10.1177/0269881121991554 (opens in new tab) Feeling Mental health Indigenous Demography

Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2

The Journal of Clinical Psychiatry February 23, 2021 Avinash Hosanagar, Joseph Cusimano, Rajiv Radhakrishnan 1 citation

P sychedelics have recently gained attention as compounds with therapeutic potential in the treatment of psychiatric disorders.The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designations for (±)-3,4-methylenedioxymethamphetamine (MDMA) as an adjunct to psychotherapy in severe posttraumatic stress disorder (PTSD) (in 2017) and for the adjunctive use of psilocybin with...